A NEW trial has revealed that metformin can modestly but meaningfully reduce weight gain in young people treated with second generation antipsychotics, offering clinicians a valuable tool for protecting long-term health.
A NEW trial has revealed that metformin can modestly but meaningfully reduce weight gain in young people treated with second generation antipsychotics, offering clinicians a valuable tool for protecting long-term health.